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While the overall prevalence of hepatitis B virus
(HBV) infection in Portugal is around 1%, there
are no published studies examining HBV geno-
types in this country. This study aimed to survey
HBV genotypes in the northern Portugal and
to examine the possible associations between
genotypes and gender, viral transmission routes,
viral markers, viral load, and biochemical
tests of liver function. The study sample consists
of 340 patients with HBV infection of whom 42.9%
were women. Tests were carried out for HBV
genotypes and biochemical liver function while
demographic information, including alcohol
intake, was obtained from the patient files.
The results indicate the predominance of geno-
type D (60.3%) and genotype A (31.5%). Intra-
familial transmission was predominant in female
patients, while males were infected in equal
proportions by perinatal, sexual, and intrafamilial
transmission. Absence of HBeAg was found in
a significantly smaller proportion of female
patients with genotype D as compared to A
(56.6% vs. 82.1%, P¼0.028). High viral load
was associated significantly and independently
with genotype D and HBeAg. Both alanine and
aspartate aminotransferases (ALT and AST)
were associated with gender and HBeAg. Thus,
genotypes A and D were found to be the most
prevalent in the north of Portugal. Patients
infected with genotype D had higher levels of
HBV DNA. HBeAg was associated with genotype
D, viral load, and ALT and AST. J. Med. Virol.
81:1170–1176, 2009.  2009 Wiley-Liss, Inc.
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INTRODUCTION
Chronic hepatitis B virus (HBV) infection is a major
health problem, with approximately 350–400 million
virus carriers worldwide [Alter, 2003]. At present, there
is no information about the prevalence of HBV infection
in Portugal. According to the most representative
research in this field, patients infected chronically with
HBV represent approximately 1% of the Portuguese
population [Lecour et al., 1984; Santos et al., 2000].
Seven HBV genotypes (A–G) have been identified,
with a worldwide geographical distribution [Kao, 2002;
Norder et al., 2004; Halfon et al., 2006]. In addition,
genotype H was described recently in American Indian
patients [Arauz-Ruiz et al., 2002; Halfon et al., 2006].
In Europe, genotypes A and D are reported most
frequently. Genotype classification is based on an
inter-group divergence of 8% or more in the nucleotide
sequence [Okamoto et al., 1988]. In addition to geno-
types, stable HBV mutant strains displaying changes
in the precore, core, surface, and polymerase gene
sequences are found frequently, and mutants unable
to achieve synthesis of HBeAg are particularly common
[Avellon and Echevarria, 2006].
It was suggested that HBV genotypes may influence
the clinical outcome of HBV infection [Kao et al., 2000].
Although the relationship between HBV genotype and
pathogenicity remains largely unknown [Bahri et al.,
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2006], current research indicates that an increase in the
viral load is associated with liver injury, independent
of serum alanine aminotransferase (ALT) levels or the
presence of the HBeAg in the serum [Chen et al., 2007b;
Wu et al., 2007].
Alcohol consumption in Portugal is 15% higher than
in the rest of Europe [WHO, 2008b]. It is estimated that
there are approximately 1 million alcoholics or excessive
alcohol drinkers in Portugal [WHO, 2008b]. In 2003,
a WHO survey showed an annual pure alcohol con-
sumption of 9.49 L per capita [WHO, 2008a]. While this
study does not suggest an association between alcohol
consumption and severity of liver disease, it may be
an important confounding factor for the incidence of
hepatitis B.
The north of Portugal is populated by approximately
3.7–4 million inhabitants, with a slight predominance of
females (51.62%), making up one-third of the country’s
total population. The region is characterized by an
industrialized, and heavily populated western Atlantic
coast, and a rural and sparsely populated interior
plateau. In the north of the country, around 30% of the
population is less than 25 years old, making this region
one of the youngest in Portugal [INE, 2008]. At present,
4% of the population of Portugal consists of immigrants
from Africa, Brazil, and Eastern Europe, although the
north of the country has relatively fewer immigrants
than the country as a whole [MAI, 2008].
The aim of this study was to assess the characteristics
and distribution of HBV genotypes in the northern
region of Portugal, and to identify the association
between HBV genotypes linked with patient demo-
graphics, including alcohol intake and viral trans-
mission routes. Viral markers for HBV, HCV (hepatitis
C virus), and HIV (human immunodeficiency virus)
were also considered, as was alcohol intake.
MATERIALS AND METHODS
Patients
The study population was composed of patients with
HBV infection, documented by the presence of the
HBsAg in the serum for at least 6 months. These
patients were observed in the two hospitals in the city of
Oporto: the Hospital de Santo Anto´nio (HSA), where
there is a hepatitis clinic, and the Hospital Joaquim
Urbano (HJU), specializing in infectious diseases. Along
with the Hospital de Sa˜o Joa˜o, these hospitals cover the
majority of the patients from the north of Portugal.
The demographics, clinical, and medical history of the
patients were retrieved from medical files. Demographic
characteristics include age, gender, place of birth and
residence, marital status, and alcohol consumption
(categorized as less than or greater than 20 g/day). The
presumed sources of HBV infection were also identified,
with information provided by physicians, based on
the clinical history and responses to a questionnaire.
Four categories were considered: (1) perinatal trans-
mission, (2) sexual intercourse, (3) intrafamilial sources
of infection, and (4) other sources, including at least one
incidence of intravenous drug use, blood transfusion,
occupational exposure, iatrogenic exposure (e.g., endos-
copy or coloscopy examination, history of surgery,
acupuncture, or hemodialysis), or unknown. Sexual
transmission was recorded for patients with a sexual
partner infected with HBV. Intrafamilial transmission
was recorded when all other routes of transmission were
excluded.
Detection of Viral Markers in Serum
Serum samples were tested for HBsAg, antibody
to HBsAg (anti-HBs), antibody to HBV core antigen
(anti-HBc), HBeAg, and antibody to HBeAg (anti-HBe).
Tests for co-infection by HCV and HIV types 1 and
2 were also performed. All tests were carried out by
automated chemiluminiscent assays (Vitros ECi, Ortho-
Clinical Diagnostics, Amersham, Buckinghamshire,
UK).
HBV DNA Quantitation
HBV DNA levels were determined using the
VERSANT1 HBV DNA 3.0 assay (bDNA) (Bayer,
Tarrytown, New York), a signal amplification nucleic
acid probe assay for direct DNA quantitation. The
assay quantification range is 357–17,900,000 HBV
DNA IU/ml.
HBV Genotyping
HBV genotypes were identified by the TRUGENE1
HBV genotyping kit. When used in conjunction with
the Open Gene1 DNA Sequencing System (Bayer), this
kit provides a method for obtaining bi-directional
sequences from overlapping surface antigens and
domains B through E of the HBV genome reverse
transcriptase region. The HBV genotype was identified
automatically by comparing the sequence with a library
of DNA sequences from the known HBV genotypes.
Biochemical Tests of Liver Function
ALT and AST (aspartate aminotransferase) were
determined by enzyme tests without piridoxalphos-
phate. g-glutamil transpeptidase (GGT) was determined
by an enzyme test with g-glutamil phosphatase. All tests
were performed using the Cobas Integra 800 (Roche,
Mannheim, Germany). Levels were considered above
the normal range for results higher than 36, 30, and
66 U/L, respectively.
Statistical Analysis
Statistical analysis was performed using SPSS
(version 16.0) and STATA (version 9.0) software with
two-sided significance set at 5% throughout.
Qualitative variables were described as percentages
and quantitative variables as mean, median, or
geometric mean where necessary.
Proportions were compared using the Pearson w2 test
(with continuity correction) as appropriate, or by Fisher’s
exact test. Continuous variables were compared with the
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t-test, after log transformation so that assumptions were
met, if necessary.
Statistical analysis of binary outcomes was performed
using multivariable logistic regression analysis.
Statistical analysis of viral load (a continuous variable)
was performed using multiple linear regression ana-
lysis, to see which variables were associated with
the outcome. Viral load was converted to a natural
logarithm to normalize its skewed distribution of
residuals and reduce the influence of outlying high
values on regression coefficients, and adequately specify
the relation of the considered outcome and independent
variables. As a first step, factors found to be associated
significantly at P<0.15 in univariable regression
were considered in a multiple regression analysis. In
the second stage, a stepwise approach was applied. Both
forward and backward selection methods were used to
obtain the smallest number of explanatory variables to
provide a well-identified model. The continuous variable
modeling was tested by the fractional polynomial
method, a procedure that make use of the full informa-
tion available in the data when a linear relationship is
not assumed [Royston and Altman, 1994]. Fractional
polynomial modeling confirmed that the association
with age was linear. Specific interactions between
parameters of interest were also investigated, but none
of these were significant. The Hosmer–Lemeshow
goodness of fit test was used to check for lack of fit of
the final logistic model. The determination coefficient
was assessed for the final linear model.
RESULTS
The distribution of HBV genotypes among the
340 patients studied is shown in Table I. Genotypes
D (60.3%) and A (31.5%) were predominant, and
genotypes C, E, and F were found in minor proportions.
Characteristics of patients infected by HBV strains from
genotypes A and D are summarized in Table II.
Virological markers found among these latter
patients are shown in Table III. Two patients infected
by genotype D were negative for anti-HBc, and one of
these was positive for HBeAg. Among female patients,
absence of HBeAg was significantly more common in
patients infected by HBV genotype A strains.
Co-infection with HCV was observed in 16 (5.5%)
individuals, co-infection with HIV 1 and 2 was only
found in males, three of whom were infected by genotype
A and two additional patients with genotype D.
Determination of HBV DNA levels showed that the
proportion of undetectable DNA values (as defined in
the Materials and Methods Section) was similar for
genotypes A and D (8.4% vs. 7.3%). However, the
proportion of patients with values higher than the
upper limit of the assay (17,900,000 IU/ml) was smaller
in genotype A than genotype D (9.3% vs. 22%). When the
viral load was examined for values between 357 and
17,900,000, a significantly higher level (P< 0.001) of
viral load was observed in genotype D (geometric mean
391,954.1; 95% CI 238,828.3–643,321.6) as compared to
patients with genotype A (geometric mean 95,463.6;
95% CI 54,268.54–167,929.6).
Only gender, HBV genotypes and HBeAg were found
to be associated significantly with HBV DNA levels
in the univariable analysis: females, patients with
genotype D and HBeAg had a higher viral load
(Table IV). Multiple regression analysis showed that
the viral load was associated significantly with genotype
D and HBeAg, with gender being excluded from the
equation.
Biochemical tests of liver function (Table V) were
performed at the same time as genotyping. In order to
investigate these parameters, the percentage of upper
reference values was calculated, and the median and the
range were estimated only for those values.
ALT was elevated in a smaller proportion of female
patients with genotype A (27%), as compared to those
with genotype D (40.7%). However, in male patients
elevated ALT levels were observed in a similar propor-
tion in the two genotypes, but in much higher proportion
than in females (around 60%).
The proportion of elevated values of AST in female
patients was the same as for ALT in both genotypes;
however, they did not correspond to the same patients.
Again, a larger proportion of male patients with
increased AST values were observed.
Elevated levels of GGT seem to be higher in patients
with genotype A than in genotype D, regardless of
gender.
In order to identify any association between increased
levels of ALT and gender, age, genotype, HBeAg, and
the presumed source of HBV infection, a univariable
analysis by logistic regression was carried out
(Table VI).
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TABLE I. Genotypes Distribution and Origin
Genotype
Portuguese Non-Portuguese
Originn % n %
A 103 32.1 4 21.1 Two from Central Europe and two from Africa
C 0 0.0 2 10.5 China
D 201 62.6 4 21.1 Two from Oriental Europe and two from Africa
E 3 0.9 9 47.4 Africa
F 13 4.0 0 0.0
D and F 1 0.3 0 0.0
Total 321 100 19 100
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For patients with high ALT serum levels, three factors
were found to be significant in the univariable analysis:
gender, age, and HBeAg. After adjusting for the
effects of other variables, multiple regression analysis
showed that only gender and HBeAg was associated
significantly with ALT. The multiple logistic regression
analysis showed males having a significantly higher
probability of increased ALT levels compared to females
(OR¼3.835; 95% CI 2.234–6.586; P< 0.001) and that
patients with HBeAg were more likely to have increased
ALT levels than patients without HBeAg (OR¼3.020;
95% CI 1.695–5.381; P<0.001).
In addition, males were also more likely to have
increased AST levels than females (OR¼2.086; 95% CI
1.245–3.496; P¼0.005), after adjusting for the effects of
the other variables in the model. Furthermore, patients
with HBeAg had a significantly higher probability of an
increased level of AST (OR¼ 2.414; 95% CI 1.412–4.127;
P¼ 0.001).
After adjusting for the effects of the other variables in
the model, increased GGT serum levels were associated
marginally with being male (OR¼2.009; 95% CI 1.005–
4.016; P¼ 0.048) and with increasing age of the patient
(OR¼ 1.021; 95% CI 0.999–1.044; P¼0.060).
DISCUSSION
The results of the study show that in the north of
Portugal, HBV genotype D was predominant (60.3%),
followed by genotype A (31.5%). These results are
consistent with research that shows that genotype D is
the most common genotype in Mediterranean countries
[Echevarria et al., 2005; Ezzikouri et al., 2008].
Genotypes C, E, F, and dual infection by genotype D
and F were also observed in the population studied. All
patients with genotype F were born in mainland
Portugal. The patients with genotype E (n¼12)
included nine cases from Angola and one patient each
from Mozambique, S. Tome, and Guinea-Bissau. The
small prevalence of genotype E can be explained by the
low immigration levels in this area, but may suggest a
special category for people originating from or traveling
frequently to the former Portuguese colonies.
The two most representative genotypes, A and D, were
the focus of this study. With both genotypes, males
J. Med. Virol. DOI 10.1002/jmv
TABLE III. Detection of Virological Markers in Serum
Genotype A
(n¼ 107)
Genotype D
(n¼ 205)
n % n %
Anti-HBc positive
Female 28/28 100.0 84/84 100.0
Male 58/58 100.0 97/99 98.0
HBeAg negative
Female* 23/28 82.1 47/83 56.6
Male 42/58 72.4 68/99 68.7
Anti-HBe positive
Female 23/38 82.1 43/83 51.8
Male 39/69 67.2 62/99 62.6
Anti HCV positive
Female 1/34 2.9 4/84 4.8
Male 4/66 6.0 7/105 6.7
Anti-HIV 1 and 2 positive
Female 0/65 0.0 0/105 0.0
Male 3/65 4.6 2/105 1.9
*P< 0.05.
TABLE II. Demographic Characteristics of Individuals With Genotypes A and D*
Genotype A (n¼ 107) Genotype D (n¼ 205)
n % n %
The presumed source of HBV infection
Perinatal transmission
Female 9/38 23.7 18/92 19.6
Male 13/69 18.8 15/113 13.3
Sexual transmission
Female 5/38 13.2 14/92 15.2
Male 13/69 18.8 19/113 16.8
Intrafamilial transmis-
sion
Female 15/38 39.5 37/92 40.2
Male 13/69 18.8 27/113 23.9
Othersa
Female 9/38 23.7 23/92 25.0
Male 30/69 43.5 52/113 46.0
Alcohol intake >20 g/day
Female 6/33 18.2 19/76 25.0
Male 27/58 46.6 50/96 52.1
Median ageSD
Female 48.82 11.97 41.41 14.55
Male 43.03 13.73 43.88 15.80
*Total for each variable may not sum to the sample size due to missing data.
aOther sources, including at least one incidence of intravenous drug use, blood transfusion, occupational
exposure, iatrogenic exposure (e.g., endoscopy or coloscopy, history of surgery, acupuncture, or
hemodialysis), or unknown.
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represented an increased prevalence of cases. The
unequal gender distribution (57.1% male) observed,
is in accordance with most published research. The
median patient age was identical for patients with
genotypes D and A, irrespective of gender.
Intrafamilial transmission appears to be the predo-
minant presumed source of HBV infection in female
patients (about 40% for both genotypes), while in
male patients this was reduced to about 20%. Sexual
transmission as the presumed source of infection was
increased slightly in males, while perinatal trans-
mission was increased in females.
Similar European studies carried out in the
Netherlands [Toy et al., 2008] and France [Grand-
jacques et al., 2000] examining the transmission routes
of HBV have shown that genotype A was found most
often in patients considered with infection transmitted
by the sexual route. In contrast, genotype D was most
often found in patients with perinatal transmission.
An examination of alcohol intake revealed that
males consumed more alcohol than females, irrespective
of HBV genotypes. Increased alcohol consumption in
males is consistent with the findings in the WHOSIS
report [WHO, 2008b].
Anti-HBc was not found only in two male cases with
genotype D, one with HBeAg and the other without
HBeAg. The absence of anti-HBc may be explained by
the existence of a precore stop codon mutation in HBeAg
seroconversion, but the existence of this mutation was
not sought [Chen et al., 2007a]. This situation must be
taken into consideration and investigated routinely,
since this atypical pattern can also reflect unusual HBV
infection [Echevarria and Leon, 2004].
In female patients, absence of HBeAg was observed in
a significantly smaller percentage in genotype D than
in genotype A patients (56.6% vs. 82.1%, P¼0.028). In
male patients, a similar proportion (about 70%) was
observed with both genotypes. In contrast with this
result, another Spanish study [Sanchez-Tapias et al.,
2002] found that absence of HBeAg was more prevalent
in patients with genotype D.
Co-infection with HCV or HIV 1 and 2 was observed in
only a small proportion of patients.
Increased levels of viral load were associated signi-
ficantly and independently with genotype D and with
HBeAg.
Some investigators found that HBV infection
remained active after seroconversion to anti-HBe in
nearly 40% of patients with genotype D. These findings
may explain the high prevalence of genotype D found
in patients with chronic hepatitis B and anti-HBe in
Mediterranean countries [Rodriguez-Frias et al., 1995;
Grandjacques et al., 2000].
Many biochemical tests that detect abnormal liver
function can indicate liver disease, but do not define the
cause. The most common blood tests that assess liver
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TABLE IV. Significant Predictors of Viral Load* by Linear Regression**
Univariable analysis Multivariable analysisa
Unstandardized
coefficients CI 95% P
Unstandardized
coefficients CI 95%
Standardized
coefficients P
Gender (female as
reference)
0.826 1.594 0.058 0.035
Age 0.023 0.049 0.004 0.096
Genotype (genotype A
as reference)
0.471 0.214 0.727 <0.001 0.379 0.109 0.649 0.181 0.006
HBeAg (negative
as reference)
2.668 1.743 3.593 <0.001 2.539 1.624 3.453 0.358 <0.001
*ln viral load.
**Two hundred thirty-three individuals with viral load of between 357 and 17,900,000 IU/ml (quantification limits of VERSANT HBV DNA 3.0
assay (bDNA)).
aThe model accounts for 17% variability of the viral load.
TABLE V. Biochemical Tests of Liver Function Greater Than Reference Values*
Genotype A (n¼ 107) Genotype D (n¼ 205)
n % Median Range n % Median Range
ALT
Female 10/37 27.0 71.5 40.0; 396.0 35/86 40.7 75.0 37.0; 1,044.0
Male 38/64 59.4 64.5 37.0; 608.0 69/107 64.5 57.0 37.0; 272.0
AST
Female 10/37 27.0 56.0 32.0; 208.0 35/86 40.7 51.0 31.00; 871.0
Male 36/64 56.3 52.0 37.0; 702.0 52/107 48.6 45.0 31.0; 1,000.0
GGT
Female 4/35 11.4 163.50 97.0; 256.0 7/81 8.6 76.0 68.0; 149.0
Male 16/64 25.0 150.00 69.0; 1,400.0 15/104 14.4 114.0 72.0; 210.0
*Parameters were evaluated only for a fraction of patients.
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function include ALT, AST, and GGT. Blood levels of
these enzymes are elevated roughly according to the
degree of liver damage. ALT, AST, and GGT enzymes
were also evaluated and associated with gender, age,
genotype, HBeAg, and presumed transmission routes
using multivariable analysis, which adjusts for the
differences in the distribution of, and associations
among, the other variables in the model. Two factors
were found to be associated significantly and indepen-
dently with increased levels of ALT, male gender
(OR¼3.835; 95% CI 2.234–6.586; P< 0.001), and
HBeAg-positivity (OR¼3.020; 95% CI 1.695–5.381;
P<0.001). A study conducted in San Francisco (USA)
reported higher mean levels of ALT with infection with
genotype A than with genotype D [Kato et al., 2004].
However, in this study, after controlling for gender and
the presence of HBeAg, no significant differences were
found between genotypes A and D.
Similarly, with regards to AST, only gender and
HBeAg were associated significantly and indepen-
dently. After adjusting for the effects of the other
variables in the model, men were more likely to have
increased levels of AST than women (OR¼ 2.086; 95%
CI 1.245–3.496; P¼ 0.005). Patients with HBeAg
had a significantly higher probability of having an
increased level of AST (OR¼2.414; 95% CI 1.412–4.127;
P¼0.001). In Spain, [Sanchez-Tapias et al., 2002] a
comparison of AST values in patients with genotypes A
and D did not reveal any significant differences;
however, the investigators did not control for possible
confounding variables. In this sample, elevated levels of
GGT were associated marginally with being male and
with increasing age.
In summary, this study examined a sample of people
infected with HBV living in the north of Portugal, where
genotypes A and D are predominant. Men and women
differed in the distribution of presumed routes of
transmission. While the most frequent transmission in
female patients was intrafamilial, male patients were
infected equally by perinatal, sexual, and intrafamilial
paths. Alcohol intake was predominant among men. In
female patients, absence of HBeAg was observed in
a significantly smaller proportion of females with D
genotype, as compared to those with A genotype, while
in males statistically significant differences were not
observed. HBeAg is associated with more severe liver
damage.
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TABLE VI. Factors Associated With Increased Levels of ALT, AST, and GGT by Logistic Regression
Univariable analysis Multivariable analysisa
Unadj. OR CI 95% P Adj. OR CI 95% P
ALT
Gender (female as reference) 2.898 1.793 4.684 <0.001 3.835 2.234 6.586 <0.001
Age 0.982 0.966 0.998 0.026
Genotype (genotype A as reference) 1.290 0.797 2.090 0.300
HBeAg (negative as reference) 2.420 1.418 4.128 0.001 3.020 1.695 5.381 <0.001
Infectionb 0.602
Sexual 1.461 0.679 3.141 0.332
Intrafamiliar 1.174 0.600 2.297 0.640
Others 1.507 0.775 2.930 0.227
AST
Gender (female as reference) 1.838 1.144 2.952 0.012 2.086 1.245 3.496 0.005
Age 1.005 0.990 1.022 0.496
Genotype (genotype A as reference) 0.981 0.605 1.591 0.939
HBeAg (negative as reference) 2.206 1.309 3.717 0.003 2.414 1.412 4.127 0.001
Infectionb 0.393
Sexual 1.687 0.781 3.646 0.183
Intrafamiliar 1.028 0.519 2.034 0.937
Others 1.410 0.721 2.757 0.315
GGT
Gender (female as reference) 1.981 0.995 3.943 0.052 2.009 1.005 4.016 0.048
Age 1.021 0.999 1.043 0.065 1.021 0.999 1.044 0.060
Genotype (genotype A as reference) 0.561 0.298 1.057 0.074
HBeAg (negative as reference) 1.129 0.546 2.333 0.744
Infectionb 0.133
Sexual 2.293 0.724 7.258 0.158
Intrafamiliar 1.270 0.409 3.948 0.679
Others 2.686 0.953 7.573 0.062
aHosmer–Lemeshow test (ALT: w2¼0.003, P¼ 0.999; AST: w2¼0.012, P¼ 0.994; GGT: w2¼ 9.566, P¼0.297).
bThe presumed source of HBV infection (perinatal as reference).
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